Related Experiment Video
Updated: Jun 18, 2026

07:42
Quasistatic Mechanical Testing for Computer-Aided Design and Manufacturing Occlusal Veneers Cemented to Milled Dentin Analog Material
Published on: December 20, 2024
High failure rate of the Duraloc Constrained Inlay
Gerold Labek1, Erich Brabec, Stephan Frischhut
1Department of Orthopaedic Surgery, Medical University Innsbruck, Innsbruck, Austria. gerold.labek@efort.org
Acta Orthopaedica
|November 18, 2009
Summary
The Duraloc Constrained Inlay frequently fails in patients experiencing recurrent hip dislocations after total hip arthroplasty. This implant design leads to unacceptably high revision surgery rates due to mechanism failure.
Area of Science:
- Orthopedic surgery
- Biomedical engineering
- Implant design
Background:
- Hip dislocations are a common complication following total hip arthroplasty.
- Recurrent dislocations present significant treatment challenges in some patients.
- Various implants and antiluxation mechanisms are employed in surgical management.
Purpose of the Study:
- To evaluate the clinical performance of the Duraloc Constrained Inlay in patients with recurrent hip dislocations.
- To assess the failure rates and mechanisms associated with this specific constrained inlay design.
Main Methods:
- A retrospective follow-up study was conducted.
- Nine Duraloc Constrained Inlays were implanted in 8 patients between October 2003 and November 2006.
- Patients were treated for recurrent dislocations post-total hip arthroplasty.
Main Results:
- All 9 implanted Duraloc Constrained Inlays failed.
- The failure mechanism involved the expanding ring being squeezed out of the polyethylene notch.
- Impingement, attributed to the implant design, was identified as the cause of failure.
- Three patients required revision surgery at the time of the study.
Conclusions:
- The Duraloc Constrained Inlay demonstrated unacceptably high failure rates.
- The design of the Duraloc Constrained Inlay contributes to its failure mechanism.
- This inlay is not recommended for managing recurrent hip dislocations.
